\-\ Texto\\:\\ \ \(0\)\
\-\ the\\ patient\\ had\\ an\\ essentially\\ normal\\ physical\\ exam\\,\\ except\\ for\\ minor\\ neurological\\ deficits\\.\\ the\\ patient\\ demonstrated\\ minor\\ loss\\ of\\ motor\\ and\\ sensory\\ function\\ in\\ the\\ right\\ arm\\,\\ and\\ a\\ slight\\ widening\\ of\\ gait\\ on\\ turning\\.\\ \ \(0\)\
\-\ csf\\ analysis\\ conducted\\ after\\ the\\ mri\\ imaging\\ demonstrated\\ no\\ malignant\\ cells\\,\\ 4\\ wbc\\,\\ 2\\ rbc\\,\\ protein\\ 41\\,\\ glucose\\ 72\\,\\ negative\\ oligo\\-clonalbands\\,\\ normal\\ igg\\ levels\\.\\ blood\\ labs\\ showed\\ negative\\ ana\\,\\ esr\\ 0\\,\\ lyme\\ negative\\,\\ and\\ spep\\ normal\\.\ \(0\)\
\-\ the\\ csf\\ analysis\\ was\\ not\\ consistent\\ with\\ an\\ infection\\,\\ and\\ therefore\\ the\\ patient\\ was\\ treated\\ with\\ steroids\\ and\\ the\\ symptoms\\ improved\\.\\ the\\ lesions\\ shows\\ good\\ response\\ to\\ steroids\\ radiographically\\ as\\ well\\ as\\ clinically\\.\ \(0\)\
\-\ bilateral\\ pontine\\ lesions\\ with\\ left\\ more\\ than\\ right\\.\\ the\\ lesion\\ is\\ shown\\ to\\ have\\ hyperintensity\\ on\\ t2\\ and\\ flair\\,\\ although\\ minimal\\ on\\ t1\\.\ \(0\)\
\-\ grading\\ gliomas\\ using\\ rcbv\\ perfusion\\ imaging\ \(0\)\
\-\ \\>\\>\\ low\\ grade\\ glioma\ \(0\)\
\-\ \\>\\>\\ demyelination\ \(1\)\
\-\ \\>\\>\\ infection\ \(1\)\
\-\ \\>\\>\\ ischemic\\ infarcts\ \(1\)\
\-\ patient\\ is\\ a\\ 60\\ yo\\ rhd\\ male\\ that\\ presented\\ with\\ a\\ 4\\ wk\\ history\\ of\\ subacute\\ onset\\ disequilibrium\\.\\ his\\ neurological\\ complaints\\ were\\ significant\\ for\\ loss\\ of\\ balance\\ especially\\ in\\ the\\ dark\\ and\\ in\\ turning\\,\\ as\\ well\\ as\\ diplopia\\ on\\ lateral\\ gaze\\ bilaterally\\.\\ the\\ patient\\ also\\ complained\\ of\\ mild\\ numbness\\ in\\ right\\ lateral\\ forearm\\ and\\ hand\\.\ \(0\)\
\-\ a\\ diffuse\\ pontine\\ lesion\\ that\\ shows\\ hyperintensity\\ on\\ t2\\ and\\ flair\\ is\\ suspicious\\ for\\ a\\ mass\\ as\\ well\\ as\\ demyelination\\.\\ the\\ extensive\\ csf\\ analysis\\ and\\ the\\ lack\\ of\\ stereotypical\\ localization\\ of\\ the\\ lesions\\ makes\\ demyelination\\ less\\ likely\\.\\ the\\ mr\\ spectroscopy\\ was\\ instrumental\\ in\\ differentiating\\ the\\ lesion\\ between\\ a\\ tumor\\ versus\\ an\\ infection\\,\\ the\\ former\\ having\\ the\\ elevatred\\ choline\\ level\\ as\\ was\\ the\\ case\\ here\\,\\ and\\ the\\ latter\\ having\\ the\\ elevation\\ in\\ lactate\\.\\ \ \(0\)\
\-\ with\\ the\\ presumptive\\ diagnosis\\ of\\ tumor\\,\\ the\\ grading\\ of\\ the\\ tumor\\ comes\\ to\\ play\\,\\ and\\ the\\ dwi\\ proves\\ to\\ be\\ instrumental\\ in\\ demonstrating\\ the\\ lack\\ of\\ extensive\\ neo\\-vascularization\\ as\\ would\\ be\\ expected\\ of\\ a\\ high\\ grade\\ tumor\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\>\\:\\ 0\\.06583576845608266\ \(0\)\
\-\ demyelination\\:\\ 0\\.04939151485249869\ \(0\)\
\-\ instrumental\\:\\ 0\\.044735687740860224\ \(0\)\
\-\ turning\\:\\ 0\\.03904972105673427\ \(0\)\
\-\ analysis\\:\\ 0\\.03782269830706013\ \(0\)\
\-\ grading\\:\\ 0\\.03720361247053987\ \(0\)\
\-\ pontine\\:\\ 0\\.03373789072702903\ \(0\)\
\-\ csf\\:\\ 0\\.031030385667878368\ \(0\)\
\-\ as\\:\\ 0\\.029972811730878325\ \(0\)\
\-\ hyperintensity\\:\\ 0\\.027273301795902535\ \(0\)\
\-\ oligo\\-clonalbands\\:\\ 0\\.025552227315844923\ \(0\)\
\-\ elevatred\\:\\ 0\\.025552227315844923\ \(0\)\
\-\ neo\\-vascularization\\:\\ 0\\.025552227315844923\ \(0\)\
\-\ minor\\:\\ 0\\.025418560145641648\ \(0\)\
\-\ stereotypical\\:\\ 0\\.023543105053352328\ \(0\)\
\-\ steroids\\:\\ 0\\.023302770309389896\ \(0\)\
\-\ tumor\\:\\ 0\\.02309834552592245\ \(0\)\
\-\ having\\:\\ 0\\.022754604613013013\ \(0\)\
\-\ flair\\:\\ 0\\.022711180429075866\ \(0\)\
\-\ lack\\:\\ 0\\.022540665152517646\ \(0\)\
\-\ negative\\:\\ 0\\.022192349229346733\ \(0\)\
\-\ infection\\:\\ 0\\.021600144122372236\ \(0\)\
\-\ rcbv\\:\\ 0\\.021533982790859732\ \(0\)\
\-\ rhd\\:\\ 0\\.021533982790859732\ \(0\)\
\-\ neurological\\:\\ 0\\.02143492528434634\ \(0\)\
\-\ spep\\:\\ 0\\.020358721607937516\ \(0\)\
\-\ disequilibrium\\:\\ 0\\.020358721607937516\ \(0\)\
\-\ proves\\:\\ 0\\.020358721607937516\ \(0\)\
\-\ wk\\:\\ 0\\.019911908043220825\ \(0\)\
\-\ choline\\:\\ 0\\.019911908043220825\ \(0\)\
\-\ lesions\\:\\ 0\\.01989183048994737\ \(0\)\
\-\ extensive\\:\\ 0\\.019810757811297076\ \(0\)\
\-\ spectroscopy\\:\\ 0\\.01887806762600711\ \(0\)\
\-\ grade\\:\\ 0\\.018868619089570843\ \(0\)\
\-\ latter\\:\\ 0\\.017702806443084893\ \(0\)\
\-\ former\\:\\ 0\\.01751573826587454\ \(0\)\
\-\ play\\:\\ 0\\.01751573826587454\ \(0\)\
\-\ lactate\\:\\ 0\\.017340014724377628\ \(0\)\
\-\ igg\\:\\ 0\\.017017621579130605\ \(0\)\
\-\ ana\\:\\ 0\\.016868945363514513\ \(0\)\
\-\ gaze\\:\\ 0\\.016868945363514513\ \(0\)\
\-\ differentiating\\:\\ 0\\.016868945363514513\ \(0\)\
\-\ presumptive\\:\\ 0\\.016868945363514513\ \(0\)\
\-\ well\\:\\ 0\\.016809399591031747\ \(0\)\
\-\ conducted\\:\\ 0\\.016340477082952325\ \(0\)\
\-\ gliomas\\:\\ 0\\.016340477082952325\ \(0\)\
\-\ comes\\:\\ 0\\.016222152461154486\ \(0\)\
\-\ localization\\:\\ 0\\.016108469234623234\ \(0\)\
\-\ lyme\\:\\ 0\\.015330892461885034\ \(0\)\
\-\ balance\\:\\ 0\\.015165215900030112\ \(0\)\
\-\ lesion\\:\\ 0\\.015135262834786563\ \(0\)\
\-\ 0\\:\\ 0\\.014859823101021918\ \(0\)\
\-\ demonstrated\\:\\ 0\\.01453576801424329\ \(0\)\
\-\ diplopia\\:\\ 0\\.014454716021673633\ \(0\)\
\-\ forearm\\:\\ 0\\.014392379194946204\ \(0\)\
\-\ loss\\:\\ 0\\.014379502449092403\ \(0\)\
\-\ rbc\\:\\ 0\\.014271588770596729\ \(0\)\
\-\ \\,\\:\\ 0\\.014124003418293254\ \(0\)\
\-\ perfusion\\:\\ 0\\.014099346972130639\ \(0\)\
\-\ 72\\:\\ 0\\.014044134812795294\ \(0\)\
\-\ t2\\:\\ 0\\.01402080445652378\ \(0\)\
\-\ essentially\\:\\ 0\\.01388454125574304\ \(0\)\
\-\ 4\\:\\ 0\\.013802735682197365\ \(0\)\
\-\ makes\\:\\ 0\\.01373327820307472\ \(0\)\
\-\ radiographically\\:\\ 0\\.013684561918099704\ \(0\)\
\-\ shows\\:\\ 0\\.013619557679587703\ \(0\)\
\-\ dark\\:\\ 0\\.013543141152391205\ \(0\)\
\-\ infarcts\\:\\ 0\\.013321770199392438\ \(0\)\
\-\ glucose\\:\\ 0\\.013237748353383011\ \(0\)\
\-\ 41\\:\\ 0\\.013196633469348356\ \(0\)\
\-\ dwi\\:\\ 0\\.013156093637537516\ \(0\)\
\-\ complained\\:\\ 0\\.013076676321050227\ \(0\)\
\-\ here\\:\\ 0\\.012924085789208424\ \(0\)\
\-\ sensory\\:\\ 0\\.012814693534185679\ \(0\)\
\-\ protein\\:\\ 0\\.012709280072820824\ \(0\)\
\-\ subacute\\:\\ 0\\.012709280072820824\ \(0\)\
\-\ except\\:\\ 0\\.012541687113722779\ \(0\)\
\-\ esr\\:\\ 0\\.012541687113722779\ \(0\)\
\-\ widening\\:\\ 0\\.012477272224491735\ \(0\)\
\-\ patient\\:\\ 0\\.012414375810382435\ \(0\)\
\-\ response\\:\\ 0\\.012414257770473166\ \(0\)\
\-\ elevation\\:\\ 0\\.012233039344440314\ \(0\)\
\-\ ischemic\\:\\ 0\\.012062487170460798\ \(0\)\
\-\ expected\\:\\ 0\\.012062487170460798\ \(0\)\
\-\ suspicious\\:\\ 0\\.011927646545432121\ \(0\)\
\-\ numbness\\:\\ 0\\.011901415138128013\ \(0\)\
\-\ improved\\:\\ 0\\.01179880085682101\ \(0\)\
\-\ versus\\:\\ 0\\.011773705022782997\ \(0\)\
\-\ therefore\\:\\ 0\\.011699695451753533\ \(0\)\
\-\ slight\\:\\ 0\\.011651385154694948\ \(0\)\
\-\ normal\\:\\ 0\\.011648803953035662\ \(0\)\
\-\ imaging\\:\\ 0\\.011606225069307842\ \(0\)\
\-\ gait\\:\\ 0\\.01153401888989861\ \(0\)\
\-\ was\\:\\ 0\\.011458290112622456\ \(0\)\
\-\ deficits\\:\\ 0\\.011334039552255272\ \(0\)\
\-\ glioma\\:\\ 0\\.011167170416540844\ \(0\)\
\-\ clinically\\:\\ 0\\.010859751367380483\ \(0\)\
\-\ 60\\:\\ 0\\.010805571271693085\ \(0\)\
\-\ using\\:\\ 0\\.010752385362509905\ \(0\)\
\-\ complaints\\:\\ 0\\.010752385362509905\ \(0\)\
\-\ demonstrating\\:\\ 0\\.010752385362509905\ \(0\)\
\-\ lateral\\:\\ 0\\.010705322003620581\ \(0\)\
\-\ good\\:\\ 0\\.01059844383986078\ \(0\)\
\-\ function\\:\\ 0\\.010500178472684892\ \(0\)\
\-\ on\\:\\ 0\\.010491174092252581\ \(0\)\
\-\ the\\:\\ 0\\.010418786673316728\ \(0\)\
\-\ arm\\:\\ 0\\.010374134669961012\ \(0\)\
\-\ motor\\:\\ 0\\.010343461889292789\ \(0\)\
\-\ an\\:\\ 0\\.010275346645954173\ \(0\)\
\-\ levels\\:\\ 0\\.01022391708194772\ \(0\)\
\-\ especially\\:\\ 0\\.0101947856736767\ \(0\)\
\-\ hand\\:\\ 0\\.010180329031615717\ \(0\)\
\-\ cells\\:\\ 0\\.009931729548260862\ \(0\)\
\-\ shown\\:\\ 0\\.009931729548260862\ \(0\)\
\-\ minimal\\:\\ 0\\.009752115856234197\ \(0\)\
\-\ wbc\\:\\ 0\\.009029202465437137\ \(0\)\
\-\ malignant\\:\\ 0\\.00895266862718638\ \(0\)\
\-\ would\\:\\ 0\\.008814396749049536\ \(0\)\
\-\ labs\\:\\ 0\\.008614417411406198\ \(0\)\
\-\ that\\:\\ 0\\.00855641002063086\ \(0\)\
\-\ in\\:\\ 0\\.008550088727483432\ \(0\)\
\-\ less\\:\\ 0\\.008388231896587486\ \(0\)\
\-\ although\\:\\ 0\\.008365012407468416\ \(0\)\
\-\ bilaterally\\:\\ 0\\.008135377502967835\ \(0\)\
\-\ showed\\:\\ 0\\.008121168892532454\ \(0\)\
\-\ a\\:\\ 0\\.008046952500667271\ \(0\)\
\-\ mr\\:\\ 0\\.007870143396946186\ \(0\)\
\-\ t1\\:\\ 0\\.007850711699200706\ \(0\)\
\-\ between\\:\\ 0\\.007850711699200706\ \(0\)\
\-\ right\\:\\ 0\\.007840275731394928\ \(0\)\
\-\ onset\\:\\ 0\\.007818612249058407\ \(0\)\
\-\ be\\:\\ 0\\.007639169410689445\ \(0\)\
\-\ diffuse\\:\\ 0\\.0074985722329719276\ \(0\)\
\-\ yo\\:\\ 0\\.007453192821167426\ \(0\)\
\-\ treated\\:\\ 0\\.007414060394445969\ \(0\)\
\-\ his\\:\\ 0\\.007138808775788209\ \(0\)\
\-\ level\\:\\ 0\\.007138808775788209\ \(0\)\
\-\ likely\\:\\ 0\\.006986347727349729\ \(0\)\
\-\ low\\:\\ 0\\.006887443631496811\ \(0\)\
\-\ high\\:\\ 0\\.006778394379932799\ \(0\)\
\-\ blood\\:\\ 0\\.006760611804374781\ \(0\)\
\-\ presented\\:\\ 0\\.00675176126093452\ \(0\)\
\-\ significant\\:\\ 0\\.0066604265247948505\ \(0\)\
\-\ mild\\:\\ 0\\.006522473779510542\ \(0\)\
\-\ than\\:\\ 0\\.006489996680922533\ \(0\)\
\-\ for\\:\\ 0\\.00634007085776274\ \(0\)\
\-\ and\\:\\ 0\\.006261182808077164\ \(0\)\
\-\ more\\:\\ 0\\.006194713940035265\ \(0\)\
\-\ symptoms\\:\\ 0\\.006172920222893157\ \(0\)\
\-\ physical\\:\\ 0\\.0060768268683514155\ \(0\)\
\-\ consistent\\:\\ 0\\.006073328315452763\ \(0\)\
\-\ bilateral\\:\\ 0\\.0060110658820708525\ \(0\)\
\-\ mri\\:\\ 0\\.0056906546519264346\ \(0\)\
\-\ diagnosis\\:\\ 0\\.005687592263131652\ \(0\)\
\-\ were\\:\\ 0\\.005624018367217163\ \(0\)\
\-\ exam\\:\\ 0\\.005441257796955183\ \(0\)\
\-\ case\\:\\ 0\\.005418853428600785\ \(0\)\
\-\ have\\:\\ 0\\.005363588632942295\ \(0\)\
\-\ had\\:\\ 0\\.005344492229683213\ \(0\)\
\-\ 2\\:\\ 0\\.005333636221769699\ \(0\)\
\-\ after\\:\\ 0\\.005124641166983196\ \(0\)\
\-\ to\\:\\ 0\\.0049515143007882465\ \(0\)\
\-\ is\\:\\ 0\\.0048894850294323965\ \(0\)\
\-\ also\\:\\ 0\\.004882955343971453\ \(0\)\
\-\ male\\:\\ 0\\.0044788566315578935\ \(0\)\
\-\ of\\:\\ 0\\.0037146139384865873\ \(0\)\
\-\ not\\:\\ 0\\.0035791845557737257\ \(0\)\
\-\ mass\\:\\ 0\\.0034448145128914915\ \(0\)\
\-\ history\\:\\ 0\\.0034209117034987926\ \(0\)\
\-\ left\\:\\ 0\\.0027713196210809123\ \(0\)\
\-\ no\\:\\ 0\\.0024940410165327593\ \(0\)\
\-\ with\\:\\ 0\\.0016957126969549237\ \(0\)\
\-\ \\.\\:\\ 0\\.0015434580911889684\ \(0\)\
